Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for CheckMate 9ER is displayed, including its study design, treatment arms, eligibility criteria, outcome measures, locations, publications, and study documents.SummaryDifference100%

- Check14 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces NIH website transition updates and says both “Super Intelligence” and “Artificial Intelligence” may appear across NIH content during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check56 days agoChange DetectedA new page revision label (Revision: v3.7.0) is added, and several sponsor/organization and document-related blocks are removed from the study record, indicating a cleanup of header and metadata rather than substantive content changes.SummaryDifference18%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates an update to the study page or template version rather than to any trial content.SummaryDifference0.0%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.